Community oncology practices are on the front lines of cancer care innovation, yet they face mounting external pressures that ...

Christine Pfaff, RPh, MBA, director of clinical initiatives at the Community Oncology Alliance (COA), sees this year’s ...

COA's annual conference hits Orlando April 28, focusing on AI, targeted therapy innovation, and state-level oncology advocacy ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Radioligand therapy expands patient access in community oncology, pairing precision imaging with safe local delivery so ...

Surveillance captured 16,775 RSV-associated hospitalizations/ED visits; median age was 10 months, with 41% of ...

Global MASH cirrhosis burden is rapidly increasing, yet therapeutic and prognostic frameworks remain limited, with sparse ...

Emerging research presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting is reinforcing a critical shift ...

Delivering bispecifics and CAR T in community settings could improve access and lower costs but requires robust symptom ...

A new report shows that physical exercise can lead to numerous benefits for people with chronic kidney disease (CKD), ...

Prior authorization has become one of the clearest points where administrative complexity directly affects patient care. For ...

Clinical trials of therapies for metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis suffer from a lack of ...